Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.

Wedzicha JA, Agustí À, Brightling CE, Calverley P, Chalmers JD, Greening NJ, Han MK, Mohan D, Ng J, Papi A, Roche N, Saenz R, Samara K, Tal-Singer R, Vogelmeier CF, Yang X, Celli BR

Open source

DOI
10.1093/ajrccm/aamag226
Published
2026 Sep 1
Container
American journal of respiratory and critical care medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ajrccm/aamag226,
  title = {Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.},
  author = {Wedzicha JA and Agustí À and Brightling CE and Calverley P and Chalmers JD and Greening NJ and Han MK and Mohan D and Ng J and Papi A and Roche N and Saenz R and Samara K and Tal-Singer R and Vogelmeier CF and Yang X and Celli BR},
  year = {2026},
  journal = {American journal of respiratory and critical care medicine},
  doi = {10.1093/ajrccm/aamag226},
  url = {https://doi.org/10.1093/ajrccm/aamag226}
}

RIS

TY  - JOUR
TI  - Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.
AU  - Wedzicha JA
AU  - Agustí À
AU  - Brightling CE
AU  - Calverley P
AU  - Chalmers JD
AU  - Greening NJ
AU  - Han MK
AU  - Mohan D
AU  - Ng J
AU  - Papi A
AU  - Roche N
AU  - Saenz R
AU  - Samara K
AU  - Tal-Singer R
AU  - Vogelmeier CF
AU  - Yang X
AU  - Celli BR
PY  - 2026
JO  - American journal of respiratory and critical care medicine
DO  - 10.1093/ajrccm/aamag226
UR  - https://doi.org/10.1093/ajrccm/aamag226
ER  - 

APA

JA, W., À, A., CE, B., P, C., JD, C., NJ, G., MK, H., D, M., J, N., A, P., N, R., R, S., K, S., R, T., CF, V., X, Y., & BR, C. (2026). Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.. American journal of respiratory and critical care medicine. https://doi.org/10.1093/ajrccm/aamag226

Source records